ARCHIVES

NCI Study Tests Donor T Cells Against Breast Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

NCI-Approved Clinical Trials

July 30, 2004

Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies

April 25, 1986

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000